Lexicon Pharmaceuticals(LXRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LXRX Lexicon Pharmaceuticals

Post-Mkt 03-02 18:32:42 EST

1.56

+0.09

+6.12%

盘后1.56

+0.00-0.01%

18:22 EST

High1.58	Low1.42	Vol2.74M
Open1.42	D1 Closing1.47	Amplitude10.88%
Mkt Cap652.08M	Tradable Cap372.84M	Total Shares418.00M
T/O4.13M	T/O Rate1.15%	Tradable Shares239.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LXRX","market":"US","secType":"STK","nameCN":"Lexicon Pharmaceuticals","latestPrice":1.56,"timestamp":1772485200000,"preClose":1.47,"halted":0,"volume":2738370,"hourTrading":{"tag":"盘后","latestPrice":1.5599,"preClose":1.56,"latestTime":"18:22 EST","volume":7059,"amount":10999.416390299999,"timestamp":1772493723312,"change":-0.0001,"changeRate":-0.000064,"amplitude":0.012821},"delay":0,"changeRate":0.06122448979591842,"floatShares":239000000,"shares":418000000,"eps":-0.189102,"marketStatus":"Post-Mkt","change":0.09,"latestTime":"03-02 18:32:42 EST","open":1.42,"high":1.58,"low":1.42,"amount":4130839.907784,"amplitude":0.108844,"askPrice":1.56,"askSize":3,"bidPrice":1.54,"bidSize":60,"shortable":3,"etf":0,"ttmEps":-0.189102,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1772499600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":955080000000,"exchange":"NASDAQ","adjPreClose":1.47,"preHourTrading":{"tag":"盘前","latestPrice":1.42,"preClose":1.47,"latestTime":"09:29 EST","volume":14595,"amount":20711.387949,"timestamp":1772461782005,"change":-0.05,"changeRate":-0.034014,"amplitude":0.040816},"postHourTrading":{"tag":"盘后","latestPrice":1.5599,"preClose":1.56,"latestTime":"18:22 EST","volume":7059,"amount":10999.416390299999,"timestamp":1772493723312,"change":-0.0001,"changeRate":-0.000064,"amplitude":0.012821},"volumeRatio":1.342333,"impliedVol":1.4897,"impliedVolPercentile":0.5498},"requestUrl":"/m/hq/s/LXRX/wiki","defaultTab":"wiki","newsList":[{"id":"2614859812","title":"Lexicon Pharmaceuticals Director Raymond Debbane Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2614859812","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614859812?lang=en_us&edition=fundamental","pubTime":"2026-02-27 21:33","pubTimestamp":1772199232,"startTime":"0","endTime":"0","summary":"Raymond Debbane, a director, reported an acquisition of 2,000 common shares of Lexicon Pharmaceuticals Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexicon Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 27, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nNDL7GWw8W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Lexicon Pharmaceuticals Director Raymond Debbane Acquires Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX","BK4007","BK4139"],"gpt_icon":0},{"id":"2614704247","title":"Lexicon Pharmaceuticals Inc. to Report Fourth-Quarter 2025 Financial Results and Host Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2614704247","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614704247?lang=en_us&edition=fundamental","pubTime":"2026-02-26 21:31","pubTimestamp":1772112700,"startTime":"0","endTime":"0","summary":"Lexicon Pharmaceuticals Inc. to Report Fourth-Quarter 2025 Financial Results and Host Conference Call               Lexicon Pharmaceuticals Inc. will release its fourth quarter 2025 financial results ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nNDLyssQ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","LU0314104364.USD","BK4585","SG9999014039.USD","IE00BGHQF748.EUR","LU2210149790.SGD","IE00B64PRP62.GBP","BK4139","BK4588","SG9999014013.SGD","BK4007","IE00BKPKM429.USD","LU2210150020.SGD","SG9999014005.SGD","SG9999014021.USD","LXRX","BK4112","LU2095319765.USD","NDAQ"],"gpt_icon":0},{"id":"2614064913","title":"Insider Power Play: Major Move by Lexicon Pharmaceuticals Director Signals Growing Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=2614064913","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614064913?lang=en_us&edition=fundamental","pubTime":"2026-02-26 10:08","pubTimestamp":1772071695,"startTime":"0","endTime":"0","summary":"New insider activity at Lexicon Pharmaceuticals ( ($LXRX) ) has taken place on February 25, 2026. Lexicon Pharmaceuticals has seen a notable inside...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/insider-power-play-major-move-by-lexicon-pharmaceuticals-director-signals-growing-confidence-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/insider-power-play-major-move-by-lexicon-pharmaceuticals-director-signals-growing-confidence-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PW","LXRX","BK4234","BK4139","BK4084"],"gpt_icon":0},{"id":"2613577377","title":"Insider Makes Bold Move With Fresh Lexicon Pharmaceuticals Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2613577377","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613577377?lang=en_us&edition=fundamental","pubTime":"2026-02-24 10:10","pubTimestamp":1771899052,"startTime":"0","endTime":"0","summary":"New insider activity at Lexicon Pharmaceuticals ( ($LXRX) ) has taken place on February 23, 2026. Director Raymond Debbane has signaled confidence ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/insider-makes-bold-move-with-fresh-lexicon-pharmaceuticals-buy-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/insider-makes-bold-move-with-fresh-lexicon-pharmaceuticals-buy-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","LXRX"],"gpt_icon":0},{"id":"2613378492","title":"Lexicon Pharmaceuticals Director Raymond Debbane Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2613378492","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613378492?lang=en_us&edition=fundamental","pubTime":"2026-02-23 20:50","pubTimestamp":1771851012,"startTime":"0","endTime":"0","summary":"Raymond Debbane, Director, reported an acquisition of common shares of Lexicon Pharmaceuticals Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexicon Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 23, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDL9lfY4r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Lexicon Pharmaceuticals Director Raymond Debbane Acquires Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LXRX","BK4139"],"gpt_icon":0},{"id":"2612342143","title":"Lexicon Pharmaceuticals Director Raymond Debbane Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2612342143","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612342143?lang=en_us&edition=fundamental","pubTime":"2026-02-19 05:31","pubTimestamp":1771450300,"startTime":"0","endTime":"0","summary":"Raymond Debbane, a director, reported an acquisition of common shares of Lexicon Pharmaceuticals Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexicon Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nNDL42yKpY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Lexicon Pharmaceuticals Director Raymond Debbane Acquires Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX","BK4007","BK4139"],"gpt_icon":0},{"id":"2612604054","title":"Lexicon Pharmaceuticals Inc. Announces Date for Upcoming Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2612604054","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612604054?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:14","pubTimestamp":1771362871,"startTime":"0","endTime":"0","summary":"Lexicon Pharmaceuticals Inc. will hold its annual meeting of stockholders on April 30, 2026, in The Woodlands, Texas.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexicon Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 17, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDL2Q87kM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX","BK4007","BK4139"],"gpt_icon":0},{"id":"2611238188","title":"Lexicon Pharmaceuticals Files Initial Beneficial Ownership Statement for Avicenna Life Sci Master Fund","url":"https://stock-news.laohu8.com/highlight/detail?id=2611238188","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611238188?lang=en_us&edition=fundamental","pubTime":"2026-02-13 10:30","pubTimestamp":1770949804,"startTime":"0","endTime":"0","summary":"Lexicon Pharmaceuticals Inc. has filed an initial statement of beneficial ownership  naming Avicenna Life Sci Master Fund LP as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexicon Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 12, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nNDLb2XYsV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Lexicon Pharmaceuticals Files Initial Beneficial Ownership Statement for Avicenna Life Sci Master Fund","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX","BK4139","BK4007"],"gpt_icon":0},{"id":"2608158898","title":"Lexicon Pharmaceuticals Bolsters Capital Through Equity Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2608158898","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608158898?lang=en_us&edition=fundamental","pubTime":"2026-02-03 06:17","pubTimestamp":1770070675,"startTime":"0","endTime":"0","summary":"Lexicon Pharmaceuticals ( ($LXRX) ) just unveiled an announcement. On January 29, 2026, Lexicon Pharmaceuticals entered into an underwriting agreem...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lexicon-pharmaceuticals-bolsters-capital-through-equity-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lexicon-pharmaceuticals-bolsters-capital-through-equity-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LXRX","BK4588","BK4585","BK4139","BK4215","EQR","BK4007"],"gpt_icon":0},{"id":"2607049612","title":"BUZZ-U.S. STOCKS ON THE MOVE-ResMed, Stryker, ALX Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2607049612","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607049612?lang=en_us&edition=fundamental","pubTime":"2026-01-30 22:12","pubTimestamp":1769782350,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-ResMed, Stryker, ALX OncologyEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: http","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nL6N3YV0MZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXP","LU2242646821.SGD","XOM","ALXO","BK4532","NEM","LU0234572021.USD","VZ","CORT","CDE","BK4232","IE000M9KFDE8.USD","IE00B2Q91V27.USD","LU1150488135.SGD","APA","RMD","DECK","LU0266512473.USD","LU0170899867.USD","VEON","APD","MENS","PCVX","DVN","KYIV","IE00BFXG1179.USD","LU2347655156.SGD","LU2404859741.USD","CVX","LU0070217475.USD","LU0498741890.SGD","BK4146","SYK","TNXP","IE00BWXC8680.SGD","LXRX","SG9999002521.SGD","HL","BK4581","SNDR","ALV","LU2404859667.USD","BK4534","LU0683600562.USD","IE00BGHQF524.EUR","LU0690374615.EUR","AU","LU0345780521.USD","LU0690374961.EUR"],"gpt_icon":1},{"id":"2607092815","title":"BRIEF-Lexicon Announces Pricing Of Approximately $94.6 Million Public Offering At $1.30 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2607092815","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607092815?lang=en_us&edition=fundamental","pubTime":"2026-01-30 15:51","pubTimestamp":1769759495,"startTime":"0","endTime":"0","summary":"BRIEF-Lexicon Announces Pricing Of Approximately $94.6 Million Public Offering At $1.30 Per ShareJan 30 (Reuters) - Lexicon Pharmaceuticals Inc LXRX.O:LEXICON ANNOUNCES PRICING OF APPROXIMATELY $94.6 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nTUA94M3YF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX","BK4139","BK4007"],"gpt_icon":0},{"id":"2607850092","title":"Lexicon Pharmaceuticals Inc - Shares Offered at $1.30 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2607850092","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607850092?lang=en_us&edition=fundamental","pubTime":"2026-01-30 15:50","pubTimestamp":1769759425,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nTUA94M3YF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LXRX","BK4139","BK4007"],"gpt_icon":0},{"id":"2607092863","title":"Lexicon Announces Pricing of Approximately $94.6 Million Public Offering and Concurrent Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2607092863","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607092863?lang=en_us&edition=fundamental","pubTime":"2026-01-30 15:50","pubTimestamp":1769759425,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nTUA94M3YF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LXRX","BK4139","BK4007"],"gpt_icon":0},{"id":"2607054735","title":"BUZZ-Lexicon Pharma slides after stock offering unveil","url":"https://stock-news.laohu8.com/highlight/detail?id=2607054735","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607054735?lang=en_us&edition=fundamental","pubTime":"2026-01-30 06:14","pubTimestamp":1769724847,"startTime":"0","endTime":"0","summary":"** Shares of Lexicon Pharmaceuticals LXRX.O down 5.6% in extended trading to $1.36 as co seeks equity raise. ** Texas-based LXRX commences proposed stock offering; deal size not disclosed. ** It also intends to sell stock in private placement to an affiliate of Invus, LP, its largest stockholder, concurrently with the public offering. ** Co to use net offering proceeds from the transactions to fund continued R&D of its drug candidates and for working capital and other general purposes. ** LXRX shares on Jan 21 jumped 19% to close at $1.56 after co said U.S. FDA cleared latestage trial of diabetic nervepain drug, pilavapadin. ** Shares ended session on Thurs down 4% at $1.44. Stock up 25% to begin the year and up ~74% over the past 12 months. ** Co has roughly $550 mln market cap based on ~363.5 mln shares outstanding as of Jan 26, per the prospectus. ** 3 of 5 analysts rate the stock \"strong buy\" or \"buy\", 2 rate \"hold\"; median PT $2.10, LSEG data reflects","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nL6N3YU1DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","LXRX","BK4127","PIPR","LU0053671581.USD","JEF","BK4139","BK4007"],"gpt_icon":0},{"id":"2607051791","title":"Lexicon announces common stock offering, no amount given","url":"https://stock-news.laohu8.com/highlight/detail?id=2607051791","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607051791?lang=en_us&edition=fundamental","pubTime":"2026-01-30 05:36","pubTimestamp":1769722576,"startTime":"0","endTime":"0","summary":"Lexicon (LXRX) Pharmaceuticals announced that it has commenced an underwritten public offering to offer and sell, subject to market and other condi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lexicon-announces-common-stock-offering-no-amount-given-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lexicon-announces-common-stock-offering-no-amount-given-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LXRX","BK4007"],"gpt_icon":0},{"id":"2607516550","title":"Lexicon Announces Proposed Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2607516550","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607516550?lang=en_us&edition=fundamental","pubTime":"2026-01-30 05:31","pubTimestamp":1769722279,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nTUA4DMVMZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LXRX","BK4139","BK4007"],"gpt_icon":0},{"id":"2605517403","title":"Lexicon Pharmaceuticals to Ring the Nasdaq Closing Bell on January 27, 2026 to Celebrate 30th Anniversary","url":"https://stock-news.laohu8.com/highlight/detail?id=2605517403","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605517403?lang=en_us&edition=fundamental","pubTime":"2026-01-23 21:30","pubTimestamp":1769175000,"startTime":"0","endTime":"0","summary":"THE WOODLANDS, Texas, Jan.  23, 2026  (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc.(Nasdaq: LXRX) today announced the Company will ring the Nasdaq Stock Market Closing Bell on Tuesday, January 27,","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/23/3224764/0/en/Lexicon-Pharmaceuticals-to-Ring-the-Nasdaq-Closing-Bell-on-January-27-2026-to-Celebrate-30th-Anniversary.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXRX","BK4531","08212","BK4139","BK4007","BK4213","HCM","BK4588","REI","BK4585"],"gpt_icon":0},{"id":"2605867214","title":"BUZZ-U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2605867214","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605867214?lang=en_us&edition=fundamental","pubTime":"2026-01-21 23:49","pubTimestamp":1769010597,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers CompaniesEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nL6N3YM11M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXC","OCGN","NATH","ROCK","TRV","ALB","LU0985481810.HKD","TDY","NEM","SLB","BKR","LPTH","CDE","PLD","SCHW","LUCD","UAL","AMBQ","CBIO","BIOA","TFC","IE00BBT3K403.USD","HAL","BK4141","ALGS","INTC","LU0154245673.USD","LNG","LSTA","JNJ","LXRX","AVR","GM","OCUL","HL","IE00B775SV38.USD","LBRT","LU2430703095.HKD","KHC","CNX","BK4534","NNE","EXE","WMB","F","BK4533","IE00B29SXL02.USD"],"gpt_icon":1},{"id":"2605483858","title":"BUZZ-U.S. STOCKS ON THE MOVE-Teledyne, Arm Holdings, Nathan’s Famous","url":"https://stock-news.laohu8.com/highlight/detail?id=2605483858","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605483858?lang=en_us&edition=fundamental","pubTime":"2026-01-21 22:25","pubTimestamp":1769005524,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Teledyne, Arm Holdings, Nathan’s FamousEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsle","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nL6N3YM0P9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEM","LXRX","LU0130103400.USD","TEL","RIO.UK","TRV","SG9999002232.USD","LU0347712357.USD","AVR","LUCD","NFLX","BK4145","IE00BLSP4452.SGD","LU2272731600.USD","KHC","ALB","LU1066051811.HKD","LU2362540622.SGD","ROCK","IE0004091025.USD","LU1201861165.SGD","LU0079474960.USD","TFC","TDY","LU2272731782.SGD","SLB","BKR","SCHW","CBIO","JNJ","LU2463526074.USD","RIO.AU","BHP.AU","HL","NATH","LU0417517546.SGD","OCUL","CDE","HAL","LBRT","ARM","LU1023059063.AUD","PLD","BIOA","FCX","LPTH","PAVM","SG9999002224.SGD","UAL"],"gpt_icon":0},{"id":"2605548100","title":"BUZZ-Lexicon rises as FDA clears late‑stage test of diabetic nerve‑pain drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2605548100","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605548100?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:42","pubTimestamp":1769002979,"startTime":"0","endTime":"0","summary":"BUZZ-Lexicon rises as FDA clears latestage test of diabetic nervepain drug** Shares of drug developer Lexicon Pharmaceuticals LXRX.O rise 2.16% to $1.34 premarket** Co says U.S. FDA cleared the latestage trial of its experimental drug pilavapadin for diabetic nerve pain** Diabetic nerve pain is a condition caused by longterm high blood sugar that damages nerves** Co says the 12week study will test a 10 mg daily dose of the experimental nonopioid drug against a placebo** LXRX's pilavapadin blocks a protein involved in pain signalling, and early tests showed reduced pain without affecting opioid pathways** FDA did not ask for additional studies, co says** Shares up ~56% in 2025  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nL4N3YM1BJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","LXRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lexpharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.02},{"period":"3month","weight":0.028},{"period":"6month","weight":0.3364},{"period":"1year","weight":1.194},{"period":"ytd","weight":0.2783}],"compareEarnings":[{"period":"1week","weight":-0.005},{"period":"1month","weight":-0.0136},{"period":"3month","weight":0.0038},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1725},{"period":"ytd","weight":0.006}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Bristol-Myers Squibb Company and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.040884},{"month":2,"riseRate":0.423077,"avgChangeRate":-0.046623},{"month":3,"riseRate":0.48,"avgChangeRate":-0.019425},{"month":4,"riseRate":0.44,"avgChangeRate":0.012763},{"month":5,"riseRate":0.5,"avgChangeRate":0.029091},{"month":6,"riseRate":0.653846,"avgChangeRate":0.134775},{"month":7,"riseRate":0.5,"avgChangeRate":0.021487},{"month":8,"riseRate":0.269231,"avgChangeRate":-0.025279},{"month":9,"riseRate":0.346154,"avgChangeRate":0.011129},{"month":10,"riseRate":0.538462,"avgChangeRate":-0.006481},{"month":11,"riseRate":0.384615,"avgChangeRate":-0.041818},{"month":12,"riseRate":0.461538,"avgChangeRate":0.062158}],"exchange":"NASDAQ","name":"Lexicon Pharmaceuticals","nameEN":"Lexicon Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lexicon Pharmaceuticals(LXRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Lexicon Pharmaceuticals(LXRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Lexicon Pharmaceuticals,LXRX,Lexicon Pharmaceuticals股票,Lexicon Pharmaceuticals股票老虎,Lexicon Pharmaceuticals股票老虎国际,Lexicon Pharmaceuticals行情,Lexicon Pharmaceuticals股票行情,Lexicon Pharmaceuticals股价,Lexicon Pharmaceuticals股市,Lexicon Pharmaceuticals股票价格,Lexicon Pharmaceuticals股票交易,Lexicon Pharmaceuticals股票购买,Lexicon Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lexicon Pharmaceuticals(LXRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Lexicon Pharmaceuticals(LXRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}